Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02697591
Title An Open-Label, Dose-Escalation, Safety Study of INCAGN01876 in Subjects With Advanced or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Incyte Corporation
Indications

lung non-small cell carcinoma

renal cell carcinoma

Advanced Solid Tumor

melanoma

endometrial adenocarcinoma

Therapies

INCAGN01876

Age Groups: adult
Covered Countries USA


No variant requirements are available.